Brand Name | Status | Last Update |
---|---|---|
cymbalta | New Drug Application | 2023-08-18 |
drizalma sprinkle | New Drug Application | 2021-07-28 |
duloxetine | ANDA | 2024-01-22 |
duloxetine delayed-release | ANDA | 2017-04-21 |
duloxetine duloxetine | ANDA | 2023-11-06 |
duloxetine duloxetine hydrochloride | ANDA | 2017-08-14 |
duloxetine hcl | ANDA | 2023-03-24 |
duloxetine hydrochloride | ANDA | 2023-11-03 |
duloxetine hydrochloride delayed release | ANDA | 2019-03-14 |
duloxicaine | unapproved drug other | 2023-01-25 |
Expiration | Code | ||
---|---|---|---|
DULOXETINE HYDROCHLORIDE, CYMBALTA, LILLY | |||
2023-04-20 | NPP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Major depressive disorder | D003865 | EFO_0003761 | F22 | 3 | 14 | 32 | 27 | 17 | 92 |
Depression | D003863 | — | F33.9 | 2 | 11 | 8 | 18 | 10 | 47 |
Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 1 | 1 | 9 | 5 | 12 | 27 |
Diabetic neuropathies | D003929 | EFO_1000783 | — | 1 | 3 | 6 | 9 | 1 | 20 |
Pain | D010146 | EFO_0003843 | R52 | — | 2 | 3 | 3 | 9 | 17 |
Stress urinary incontinence | D014550 | HP_0010992 | — | — | 2 | 13 | 2 | — | 17 |
Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | 1 | 9 | 2 | 4 | 16 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | 5 | 4 | 4 | 13 |
Depressive disorder | D003866 | EFO_1002014 | F32.A | 1 | — | 5 | 4 | 2 | 12 |
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 1 | 3 | 2 | 4 | 3 | 12 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Peripheral nervous system diseases | D010523 | HP_0009830 | G64 | — | 3 | 2 | — | 1 | 5 |
Mood disorders | D019964 | EFO_0004247 | F30-F39 | 1 | — | 1 | — | 1 | 3 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | 1 | — | 2 | 3 |
Urinary incontinence | D014549 | HP_0000020 | R32 | — | 1 | 1 | — | 1 | 3 |
Neoplasms | D009369 | — | C80 | — | 1 | 1 | — | — | 2 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | 1 | — | — | 2 |
Colorectal neoplasms | D015179 | — | — | — | 2 | 1 | — | — | 2 |
Musculoskeletal pain | D059352 | — | — | — | 1 | 1 | — | — | 2 |
Mental disorders | D001523 | EFO_0000677 | F91.9 | — | — | 1 | — | — | 1 |
Psychophysiologic disorders | D011602 | — | F45.9 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alcoholism | D000437 | EFO_0003829 | F10.1 | 1 | 1 | — | — | — | 2 |
Suicidal ideation | D059020 | EFO_0004320 | R45.851 | — | 1 | — | — | 1 | 2 |
Male infertility | D007248 | EFO_0004248 | N46 | — | 1 | — | — | — | 1 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | — | — | — | 1 |
Prediabetic state | D011236 | EFO_1001121 | R73.03 | — | 1 | — | — | — | 1 |
Insulin resistance | D007333 | HP_0000855 | E88.819 | — | 1 | — | — | — | 1 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | 1 | — | — | — | 1 |
Coronary artery disease | D003324 | — | I25.1 | — | 1 | — | — | — | 1 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | — | — | — | 1 |
Traumatic brain injuries | D000070642 | — | S06 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | 1 | 2 |
Therapeutic equivalency | D013810 | — | — | 2 | — | — | — | — | 2 |
Cocaine-related disorders | D019970 | — | F14 | 2 | — | — | — | — | 2 |
Drug interactions | D004347 | — | — | 1 | — | — | — | — | 1 |
Amphetamine-related disorders | D019969 | EFO_0004701 | F15 | 1 | — | — | — | — | 1 |
Hyperalgesia | D006930 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | — | — | — | 1 | 1 |
Chemical and drug induced liver injury | D056486 | EFO_0004228 | — | — | — | — | — | 1 | 1 |
Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | — | — | — | 1 | 1 |
Pain management | D059408 | — | — | — | — | — | — | 1 | 1 |
Intractable pain | D010148 | — | — | — | — | — | — | 1 | 1 |
Wounds and injuries | D014947 | — | T14.8 | — | — | — | — | 1 | 1 |
Chronic disease | D002908 | — | — | — | — | — | — | 1 | 1 |
Brain injuries | D001930 | — | S06.9 | — | — | — | — | 1 | 1 |
Alcohol-related disorders | D019973 | — | F10 | — | — | — | — | 1 | 1 |
Acute kidney injury | D058186 | HP_0001919 | N17 | — | — | — | — | 1 | 1 |
Drug common name | Duloxetine |
INN | duloxetine |
Description | (S)-duloxetine is a duloxetine. It is an enantiomer of a (R)-duloxetine. |
Classification | Small molecule |
Drug class | antidepressants (fluoxetine type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CNCC[C@H](Oc1cccc2ccccc12)c1cccs1 |
PDB | — |
CAS-ID | 116539-59-4 |
RxCUI | — |
ChEMBL ID | CHEMBL1175 |
ChEBI ID | 36795 |
PubChem CID | 60835 |
DrugBank | DB00476 |
UNII ID | O5TNM5N07U (ChemIDplus, GSRS) |